Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats -: Effect of vitamin E on cyclosporine nephrotoxicity

被引:61
作者
Parra, T
de Arriba, G
Conejo, JR
Cantero, M
Arribas, I
Rodríguez-Puyol, D
Rodríguez-Puyol, M
Carballo, F
机构
[1] Hosp Univ Guadalajara, Unidad Invest, Nephrol Sect, Guadalajara 19002, Spain
[2] Hosp Gen Univ Guadalajara, Res Unit, Guadalajara 19002, Spain
[3] Hosp Principe Asturias Alcala de Henares, Anal Clin & Nephrol Sect, Alcala De Henares 28871, Spain
[4] Dept Physiol Pharmacol, Madrid 28871, Spain
[5] Dept Med, Madrid 28871, Spain
关键词
D O I
10.1097/00007890-199811270-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background We report an investigation of the effects of cyclosporine (CsA) on kidney function, the glomerular synthesis of reactive oxygen species, the peroxidation of lipids, and the levels of thromboxane B-2 (TXB2). The effect of the simultaneous administration of the antioxidant vitamin E (Vit E) and CsA in rats was also evaluated. Methods. Adult male Wistar rats were treated for 30 days with CsA (30 mg/kg/day), with Vit E (0.05 mg/ml), with CsA plus Vit E, or with the vehicle used for administration of CsA, namely 12.6% ethanol, Results. CsA induced kidney failure and increased the glomerular synthesis of superoxide anion, H2O2, malonyldialdehyde, and TXB2. Vit E minimized the adverse effects of CsA on kidney function and the glomerular synthesis of these compounds. Conclusions. Our results suggest that the acute decrease in glomerular filtration rate induced by CsA might be mediated by the synthesis of reactive oxygen species and subsequent peroxidation of lipids, which increases the levels of TXB2. Treatment with Vit E prevented these effects, suggesting a possible role for antioxidants in the prevention of CsA nephrotoxicity.
引用
收藏
页码:1325 / 1329
页数:5
相关论文
共 43 条
[1]  
AHMED SS, 1993, J PHARMACOL EXP THER, V265, P1047
[2]   L-arginine and allopurinol protect against cyclosporine nephrotoxicity [J].
Assis, SM ;
Monteiro, JL ;
Seguro, AC .
TRANSPLANTATION, 1997, 63 (08) :1070-1073
[3]  
AWAZU M, 1991, J AM SOC NEPHROL, V1, P1253
[4]   GLOMERULAR HEMODYNAMICS AND HORMONAL PARTICIPATION ON CYCLOSPORINE NEPHROTOXICITY [J].
BARROS, EJG ;
BOIM, MA ;
AJZEN, H ;
RAMOS, OL ;
SCHOR, N .
KIDNEY INTERNATIONAL, 1987, 32 (01) :19-25
[5]   DEXAMETHASONE AND HYDROGEN-PEROXIDE PRODUCTION BY MESANGIAL CELLS DURING PHAGOCYTOSIS [J].
BAUD, L ;
PEREZ, J ;
ARDAILLOU, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (04) :F596-F604
[6]   INCREASED URINARY-EXCRETION OF THROMBOXANE B-2 AND 2,3-DINOR-TX B-2 IN CYCLOSPORIN-A NEPHROTOXICITY [J].
BENIGNI, A ;
CHIABRANDO, C ;
PICCINELLI, A ;
PERICO, N ;
GAVINELLI, M ;
FURCI, L ;
PATINO, O ;
ABBATE, M ;
BERTANI, T ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1988, 34 (02) :164-174
[7]  
BETSCHART JM, 1988, TRANSPLANT P, V20, P880
[8]   CYCLOSPORINE A INHIBITS ENDOTHELIUM-DEPENDENT VASODILATATION AND VASCULAR PROSTACYCLIN PRODUCTION [J].
BOSSALLER, C ;
FORSTERMANN, U ;
HERTEL, R ;
OLBRICHT, C ;
RESCHKE, V ;
FLECK, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (01) :165-169
[9]   PROTECTION OF GLOMERULAR-FILTRATION RATE BY THE THROMBOXANE RECEPTOR ANTAGONIST L655,240 DURING LOW-DOSE CYCLOSPORINE ADMINISTRATION [J].
BUNKE, M ;
WILDER, L ;
MARTIN, A .
PROSTAGLANDINS, 1992, 43 (04) :351-360
[10]  
CAIRNS HS, 1990, OXFORD TXB CLIN NEPH, P1560